ArticleProbiotics and antimicrobial proteins2026
Postbiotics From Ligilactobacillus salivarius Enhance Mitochondrial Robustness Via TLR2 Signaling in Intestinal Macrophages.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Postbiotics, defined as preparations of inanimate microorganisms and/or their components, have attracted increasing attention because of their stability and functional benefits. Although lactic acid bacteria (LAB) modulate immune responses and oxidative stress, their direct effects on host mitochondrial homeostasis remain poorly understood. In this study, we investigated whether postbiotics derived from Ligilactobacillus salivarius enhance mitochondrial robustness in porcine intestinal macrophages (IPIMs). To establish a model of disrupted mitochondrial redox homeostasis, mitochondrial dysfunction was induced using the mitochondrial complex III inhibitor Antimycin A (AMA). High-dose AMA induced mitochondrial reactive oxygen species (mtROS) accumulation and suppressed the expression of antioxidant genes, including SOD2. Pre-stimulation with heat-killed L. salivarius suppressed AMA-induced mtROS production in selected representative strains, with the most effective strains enhancing SOD2 expression. These mtROS-suppressive strains selectively activated Toll like receptor (TLR)1/2 and TLR2/6 signaling, whereas non-protective strains failed to induce TLR responsiveness. Pharmacological inhibition of TLR2 abolished mtROS suppression and SOD2 induction, confirming TLR2 dependency. Furthermore, Seahorse extracellular flux analysis revealed that postbiotics enhanced mitochondrial respiration, including maximal respiration and spare respiratory capacity, via TLR2 signaling. Collectively, our findings demonstrate that postbiotics function as immunometabolic modulators that reinforce mitochondrial redox homeostasis and respiratory capacity via TLR2 signaling, highlighting a novel mechanism by which microbial components contribute to intestinal immune cell homeostasis.
Indexed as
Identifiers
42384162What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.